Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,513 | 9,142 | 18,995 | 36,842 | 55 |
| TOTAL | $1,556 | $9,628 | $19,674 | $39,572 | $73 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 392 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $392 |
| Total Assets | $1,556 | $9,628 | $19,674 | $39,572 | $465 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,469 | 1,694 | 1,095 | 2,088 | 3,116 |
| Other current liabilities | N/A | 6,000 | 2,000 | N/A | N/A |
| TOTAL | $2,469 | $7,694 | $3,095 | $2,088 | $3,660 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,022 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,022 |
| Total Liabilities | $2,469 | $7,694 | $3,095 | $2,088 | $4,682 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,063 | 47 | 47 | 47 | 20 |
| Retained earnings | -71,611 | -59,544 | -44,355 | -22,704 | -10,648 |
| TOTAL | $-914 | $1,934 | $16,579 | $37,485 | $-4,216 |
| Total Liabilities And Equity | $1,556 | $9,628 | $19,674 | $39,573 | $465 |